Biomnis

The European leader in the specialized medical pathology sector, Biomnis was renamed in 2008 after the merger of Laboratoire Marcel Merieux with Laboratoire Claude Levy. Biomnis generates a consolidated turnover of approximately €220 million and operates around ten laboratories in France and in Europe. The group has over 1600 employees and offers a very wide range of tests, including all specialized procedures for which it has obtained all the approvals required. A major player in the United Kingdom and the Middle East, Biomnis is continuing its international development. Its strategy is based on very advanced technical expertise and the control of the peripheral functions of the sector, making it possible to improve quality of service, such as logistics via its subsidiary TSE Express Médical, or I.T., via its subsidiary Openlab.